JP2025513785A5 - - Google Patents

Info

Publication number
JP2025513785A5
JP2025513785A5 JP2024559143A JP2024559143A JP2025513785A5 JP 2025513785 A5 JP2025513785 A5 JP 2025513785A5 JP 2024559143 A JP2024559143 A JP 2024559143A JP 2024559143 A JP2024559143 A JP 2024559143A JP 2025513785 A5 JP2025513785 A5 JP 2025513785A5
Authority
JP
Japan
Prior art keywords
sequence
seq
nucleic acid
rnai
identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024559143A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513785A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/065388 external-priority patent/WO2023196862A1/en
Publication of JP2025513785A publication Critical patent/JP2025513785A/ja
Publication of JP2025513785A5 publication Critical patent/JP2025513785A5/ja
Pending legal-status Critical Current

Links

JP2024559143A 2022-04-06 2023-04-05 Dm-1筋強直性ジストロフィーの標的遺伝子療法 Pending JP2025513785A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263328241P 2022-04-06 2022-04-06
US63/328,241 2022-04-06
US202363483075P 2023-02-03 2023-02-03
US63/483,075 2023-02-03
PCT/US2023/065388 WO2023196862A1 (en) 2022-04-06 2023-04-05 Targeted gene therapy for dm-1 myotonic dystrophy

Publications (2)

Publication Number Publication Date
JP2025513785A JP2025513785A (ja) 2025-04-30
JP2025513785A5 true JP2025513785A5 (cg-RX-API-DMAC7.html) 2026-04-13

Family

ID=86272086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024559143A Pending JP2025513785A (ja) 2022-04-06 2023-04-05 Dm-1筋強直性ジストロフィーの標的遺伝子療法

Country Status (12)

Country Link
US (1) US20230365968A1 (cg-RX-API-DMAC7.html)
EP (1) EP4504936A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025513785A (cg-RX-API-DMAC7.html)
KR (1) KR20240169111A (cg-RX-API-DMAC7.html)
CN (1) CN119234040A (cg-RX-API-DMAC7.html)
AU (1) AU2023248463A1 (cg-RX-API-DMAC7.html)
CA (1) CA3247417A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024013743A2 (cg-RX-API-DMAC7.html)
IL (1) IL316078A (cg-RX-API-DMAC7.html)
MX (1) MX2024012308A (cg-RX-API-DMAC7.html)
TW (1) TW202345914A (cg-RX-API-DMAC7.html)
WO (1) WO2023196862A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024211480A2 (en) * 2023-04-05 2024-10-10 Genzyme Corporation Targeted gene therapy for dm-1 myotonic dystrophy
WO2025137378A1 (en) * 2023-12-20 2025-06-26 Aavantibio, Inc. Aav capsid engineering for cardiac and/or musculoskeletal gene therapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2264482A1 (en) 1996-09-06 1998-03-12 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6995006B2 (en) 1997-09-05 2006-02-07 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6596535B1 (en) 1999-08-09 2003-07-22 Targeted Genetics Corporation Metabolically activated recombinant viral vectors and methods for the preparation and use
US7465583B2 (en) 2000-06-01 2008-12-16 The University Of North Carolina At Chapel Hill Duplexed parvovirus vectors
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
US8283151B2 (en) 2005-04-29 2012-10-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
WO2008134646A2 (en) 2007-04-26 2008-11-06 University Of Iowa Research Foundation Rna interference suppression of neurodegenerative diseases and methods of use thereof
DK2164967T3 (en) 2007-05-31 2015-10-19 Univ Iowa Res Found Reduction of off-target rna interferenstoksicitet
US9556433B2 (en) 2012-07-17 2017-01-31 Université De Genève Nucleic acids for down-regulation of gene expression
WO2018178067A1 (en) * 2017-03-27 2018-10-04 Vrije Universiteit Brussel Diaphragm-specific nucleic acid regulatory elements and methods and use thereof
EP3618839A4 (en) * 2017-05-05 2021-06-09 Voyager Therapeutics, Inc. COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
WO2018226638A1 (en) * 2017-06-05 2018-12-13 The Brigham And Women's Hospital, Inc. Vero cell lines stably expressing hsv icp0 protein
IL277270B2 (en) 2018-03-16 2025-05-01 Res Inst Nationwide Childrens Hospital Increasing tissue-specific gene delivery through capsid modification
CA3097375A1 (en) 2018-04-27 2019-10-31 Universitat Heidelberg Modified aav capsid polypeptides for treatment of muscular diseases
JP2021522836A (ja) * 2018-05-15 2021-09-02 ユニバーシティ オブ ワシントンUniversity of Washington スプライスオパシーの軽減、及びrnaドミナンス障害の治療のための組成物及び方法
TW202509215A (zh) * 2018-08-03 2025-03-01 美商健臻公司 針對α-突觸核蛋白的變體RNAi
AU2019326551A1 (en) * 2018-08-22 2021-03-18 Research Institute At Nationwide Children's Hospital Recombinant virus products and methods for inhibiting expression of dystrophia myotonica protein kinase and/or interfering with a trinucleotide repeat expansion in the 3' untranslated region of the DMPK gene
CN115279421A (zh) * 2020-01-10 2022-11-01 坚固生物科技公司 用于联合疗法的病毒载体

Similar Documents

Publication Publication Date Title
JP2020019772A5 (cg-RX-API-DMAC7.html)
JP2024009857A5 (cg-RX-API-DMAC7.html)
JP2021534814A5 (cg-RX-API-DMAC7.html)
JP2022508182A5 (cg-RX-API-DMAC7.html)
JP2021106619A5 (cg-RX-API-DMAC7.html)
JP2020532981A5 (cg-RX-API-DMAC7.html)
RU2017116576A (ru) Композиции и способы лечения бокового амиотрофического склероза (als)
JP2021512649A5 (cg-RX-API-DMAC7.html)
JP2022524434A5 (cg-RX-API-DMAC7.html)
RU2018140499A (ru) Способы и композиции для лечения хореи гентингтона
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2017510298A5 (cg-RX-API-DMAC7.html)
JP2017535266A5 (cg-RX-API-DMAC7.html)
IL273394B2 (en) RNAI variant
JP2020519284A5 (cg-RX-API-DMAC7.html)
JP2020535803A5 (cg-RX-API-DMAC7.html)
JP2021522836A5 (cg-RX-API-DMAC7.html)
JP2022525302A5 (cg-RX-API-DMAC7.html)
JP2024508696A5 (cg-RX-API-DMAC7.html)
CA3158518A1 (en) Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseases
JP2023501897A5 (cg-RX-API-DMAC7.html)
JP2023541443A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2023524024A5 (cg-RX-API-DMAC7.html)
JP2024504611A5 (cg-RX-API-DMAC7.html)